Change nos Media - The Clinic of Change

Change in the Media

NOTÍCIA SAPO | Dependência do álcool: “Disseram-me que era um caso perdido”

In an interview with Sapo, the patient at The Clinic of Change told the story of how alcohol became an addiction, his failed attempts at recovery and how psychedelic-assisted treatment helped him get back on his feet. Today, he has been drink-free for two years and looks to the future with hope.

Escetamina Spravato aprovada para depressão | SIC Notícias

This approval represents a significant advance in the treatment of resistant depression in Portugal, offering a new therapeutic option for patients who have not responded to conventional treatments.

Maria Ofélia shares her experience with psychedelic-assisted psychotherapy on RTP

The nurse met Prof. Dr. Victor Amorim Rodrigues, clinical director of The Clinic of Change, first on the small screen and only a day later, in person - "I called the clinic right after watching the interview and had an appointment the next day".

A Prof.ª Celia Morgan e a Psicoterapia Assistida por Psicadélicos na 2.ª Conferência Científica da The Clinic of Change

A investigadora explicou que, ao contrário das abordagens convencionais que muitas vezes falham em tratar as causas subjacentes da dependência, a cetamina atua nos mecanismos neurológicos responsáveis pela rigidez cognitiva associada ao vício.

Substance Abuse: Dr. Guilherme Bastos Martins Discusses the Topic in a Podcast

The doctor debated fundamental questions about the prevention, treatment and social impact of addiction, covering topics ranging from discrimination against illicit drugs to the importance of assisted consumption rooms.

Sapo: “I’m a person again.” How ketamine-assisted psychotherapy saved Bárbara’s life

It's not a miracle solution, but in cases of resistant anxiety and depression and some addictions it can really make a difference, assures Bárbara, who tells SAPO about the horror trip that took her to the bottom and how she once again saw a light that she hadn't seen for decades.

“Saber Viver”: A “journey” to combat depression

The use of psychedelic drugs has been gaining traction in the treatment of mental illness. Ketamine is the most commonly used substance in psychotherapy, but studies seem to point to benefits in the clinical use of psilocybin for treating treatment-resistant depression, addictive behaviors, eating disorders, and pain management.

«Diário de Notícias»: Droga psicadélica é recurso para saúde mental

British researcher Celia Morgan is in Lisbon for the 2nd Scientific Conference on Ketamine-Assisted Psychotherapy. She talks to DN about advances in the use of the substance. "It's encouraging to be able to offer something new."